3 patents
Utility
Method of Treatment Using ANTI-CCL24 Antibody
27 Jul 23
Provided are compositions and methods for treating fibrotic inflammatory diseases, including non-alcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc), with an anti-CCL24 monoclonal antibody.
Adi MOR, Arnon AHARON, Sharon HASHMUELI, Michal SEGAL SALTO, Neta BARASHI
Filed: 20 Apr 21
Utility
Anti CCL24 (EOTAXIN2) Antibodies for Use In the Treatment of Hepatic Diseases
24 Nov 22
Provided concerns isolated anti CCL24 (eotaxin 2) antibodies for method of treatment of hepatic pathologies.
Adi MOR
Filed: 20 Jun 22
Utility
Anti CCL24 (EOTAXIN2) antibodies for use in the treatment of hepatic diseases
21 Jun 22
Provided concerns isolated anti CCL24 (eotaxin 2) antibodies for method of treatment of hepatic pathologies.
Adi Mor
Filed: 8 Mar 18
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first